Ethema Health Corporation
GRST
$0.0004
$0.000.00%
| Weiss Ratings | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | C- | |||
| Rating Factors | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.37 | |||
| Price History | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -20.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -20.00% | |||
| 90-Day Total Return | -42.86% | |||
| Year to Date Total Return | -42.86% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | -20.00% | |||
| 3-Year Total Return | -42.86% | |||
| 5-Year Total Return | 300.00% | |||
| 52-Week High % Change | -55.00% | |||
| 52-Week Low % Change | 80.00% | |||
| Price | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Apr 25, 2024 | |||
| 52-Week High Price (Date) | Aug 19, 2024 | |||
| Valuation | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.48M | |||
| Enterprise Value | 20.61M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -233.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.64 | |||
| Price/Book (Q) | -0.50 | |||
| Enterprise Value/Revenue (TTM) | 3.63 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -14.15 | |||
| Enterprise Value/EBIT | -10.77 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 7.21B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 500 0020 | |||
| Address | 950 Evernia Street West Palm Beach, FL 33401 | |||
| Website | ethemahealth.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -33.70% | |||
| Profit Margin | -37.59% | |||
| Management Effectiveness | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.83% | |||
| Return on Equity | -- | |||
| Income Statement | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 5.68M | |||
| Total Revenue (TTM) | 5.68M | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 2.61M | |||
| EBITDA (TTM) | -1.46M | |||
| EBIT (TTM) | -1.91M | |||
| Net Income (TTM) | -2.13M | |||
| Net Income Avl. to Common (TTM) | -2.13M | |||
| Total Revenue Growth (Q YOY) | 29.99% | |||
| Earnings Growth (Q YOY) | -147.48% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -120.00% | |||
| Balance Sheet | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 60.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 472.40K | |||
| Total Preferred Equity (Q) | 0.05 | |||
| Total Equity (Q) | -7.13M | |||
| Current Ratio (Q) | 0.063 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 12.32M | |||
| Total Current Liabilities (Q) | 7.54M | |||
| Total Debt (Q) | 17.14M | |||
| Total Liabilities (Q) | 19.45M | |||
| Total Common Equity (Q) | -7.18M | |||
| Cash Flow | GRST - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.05M | |||
| Cash from Financing (TTM) | 1.44M | |||
| Net Change in Cash (TTM) | 49.10K | |||
| Levered Free Cash Flow (TTM) | -1.37M | |||
| Cash from Operations (TTM) | -332.40K | |||
